Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Science 2 May 1986:
Vol. 232. no. 4750, pp. 648 - 650
DOI: 10.1126/science.3083509
Prev | Table of Contents | Next

Articles

Science, Vol 232, Issue 4750, 648-650
Copyright © 1986 by American Association for the Advancement of Science

articles

A neuronal antigen in the brains of Alzheimer patients

BL Wolozin, A Pruchnicki, DW Dickson, and P Davies

A monoclonal antibody was prepared against pooled homogenates of brain tissue from patients with Alzheimer's disease. This antibody recognizes an antigen present in much higher concentration in certain brain regions of Alzheimer patients than in normal brain. The antigen appears to be a protein present in neurons involved in the formation of neuritic plaques and neurofibrillary tangles, and in some morphologically normal neurons in sections from Alzheimer brains. Partial purification and Western blot analysis revealed the antigen from Alzheimer brain to be a single protein with a molecular weight of 68,000. Application of the same purification procedure to normal brain tissue results in the detection of small amounts of a protein of lower molecular weight.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Regulation of Prion Gene Expression by Transcription Factors SP1 and Metal Transcription Factor-1.
S. A. Bellingham, L. A. Coleman, C. L. Masters, J. Camakaris, and A. F. Hill (2009)
J. Biol. Chem. 284, 1291-1301
   Abstract »    Full Text »    PDF »
Tau aggregation and progressive neuronal degeneration in the absence of changes in spine density and morphology after targeted expression of Alzheimer's disease-relevant tau constructs in organotypic hippocampal slices..
N. Shahani, S. Subramaniam, T. Wolf, C. Tackenberg, and R. Brandt (2006)
J. Neurosci. 26, 6103-6114
   Abstract »    Full Text »    PDF »
Increased ALZ-50 Immunoreactivity in CSF of Pseudotumor Cerebri Patients..
J.-H. F. Peng, F.-T. Kung, W. Peng, and J. C. Parker Jr (2006)
Ann. Clin. Lab. Sci. 36, 151-156
   Abstract »    Full Text »    PDF »
Accumulation of Filamentous Tau in the Cerebral Cortex of Human Tau R406W Transgenic Mice.
M. Ikeda, M. Shoji, T. Kawarai, T. Kawarabayashi, E. Matsubara, T. Murakami, A. Sasaki, Y. Tomidokoro, Y. Ikarashi, H. Kuribara, et al. (2005)
Am. J. Pathol. 166, 521-531
   Abstract »    Full Text »    PDF »
Tau filament formation and associative memory deficit in aged mice expressing mutant (R406W) human tau.
Y. Tatebayashi, T. Miyasaka, D.-H. Chui, T. Akagi, K.-i. Mishima, K. Iwasaki, M. Fujiwara, K. Tanemura, M. Murayama, K. Ishiguro, et al. (2002)
PNAS 99, 13896-13901
   Abstract »    Full Text »    PDF »
Neurodegeneration with Tau Accumulation in a Transgenic Mouse Expressing V337M Human Tau.
K. Tanemura, M. Murayama, T. Akagi, T. Hashikawa, T. Tominaga, M. Ichikawa, H. Yamaguchi, and A. Takashima (2002)
J. Neurosci. 22, 133-141
   Abstract »    Full Text »    PDF »
Correlation of rCBF (SPECT), CSF tau, and congnitive function in patients with dementia of the Alzheimer's type, other types of dementia, and congrol subjects.
M. Tsolaki, V. Sakka, G. Gerasimou, N. Dimacopoulos, O. Chatzizisi, K. N. Fountoulakis, G. Kyriazis, J. Papanastasiou, and A. Kazis (2001)
American Journal of Alzheimer's Disease and Other Dementias 16, 21-31
   Abstract »    PDF »
Alzheimer-like neurodegeneration in aged antinerve growth factor transgenic mice.
S. Capsoni, G. Ugolini, A. Comparini, F. Ruberti, N. Berardi, and A. Cattaneo (2000)
PNAS 97, 6826-6831
   Abstract »    Full Text »    PDF »
Plaque-induced neurite abnormalities: Implications for disruption of neural networks in Alzheimer's disease.
R. B. Knowles, C. Wyart, S. V. Buldyrev, L. Cruz, B. Urbanc, M. E. Hasselmo, H. E. Stanley, and B. T. Hyman (1999)
PNAS 96, 5274-5279
   Abstract »    Full Text »    PDF »
A Protein Kinase, PKN, Accumulates in Alzheimer Neurofibrillary Tangles and Associated Endoplasmic Reticulum-Derived Vesicles and Phosphorylates Tau Protein.
T. Kawamata, T. Taniguchi, H. Mukai, M. Kitagawa, T. Hashimoto, K. Maeda, Y. Ono, and C. Tanaka (1998)
J. Neurosci. 18, 7402-7410
   Abstract »    Full Text »    PDF »
Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology.
C. Sturchler-Pierrat, D. Abramowski, M. Duke, K.-H. Wiederhold, C. Mistl, S. Rothacher, B. Ledermann, K. Burki, P. Frey, P. A. Paganetti, et al. (1997)
PNAS 94, 13287-13292
   Abstract »    Full Text »    PDF »
The Structural Basis of Monoclonal Antibody Alz50's Selectivity for Alzheimer's Disease Pathology.
G. Carmel, E. M. Mager, L. I. Binder, and J. Kuret (1996)
J. Biol. Chem. 271, 32789-32795
   Abstract »    Full Text »    PDF »
Age-Dependent Neuronal and Synaptic Degeneration in Mice Transgenic for the C Terminus of the Amyloid Precursor Protein.
M. L. Oster-Granite, D. L. McPhie, J. Greenan, and R. L. Neve (1996)
J. Neurosci. 16, 6732-6741
   Abstract »    Full Text »    PDF »
Site-specific Dephosphorylation of Tau Protein at Ser[IMAGE]/Thr[IMAGE] in Response to Microtubule Depolymerization in Cultured Human Neurons Involves Protein Phosphatase 2A.
S. E. Merrick, D. C. Demoise, and V. M.-Y. Lee (1996)
J. Biol. Chem. 271, 5589-5594
   Abstract »    Full Text »    PDF »
Increased ALZ-50 Immunoreactivity in Sudden Infant Death Syndrome.
D. L. Sparks, D. G. Davis, T. Mellert Bigelow, K. Rasheed, T. M. Landers, H. Liu, C. M. Coyne, and J. C. Hunsaker (1996)
J Child Neurol 11, 101-107
   Abstract »    PDF »
Widespread Appearance of Alz-50 Immunoreactive Neurons in the Human Brain With Cerebral Infarction.
T. Uchihara, K. Tsuchiya, H. Kondo, T. Hayama, and K. Ikeda (1995)
Stroke 26, 2145-2148
   Abstract »    Full Text »
The Neuropathology of Williams Syndrome: Report of a 35-Year-Old Man With Presenile {beta}/A4 Amyloid Plaques and Neurofibrillary Tangles.
J. A. Golden, G. P. Nielsen, B. R. Pober, and B. T. Hyman (1995)
Arch Neurol 52, 209-212
   Abstract »    PDF »
Proline-directed and Non-proline-directed Phosphorylation of PHF-tau.
M. Morishima-Kawashima, M. Hasegawa, K. Takio, M. Suzuki, H. Yoshida, K. Titani, and Y. Ihara (1995)
J. Biol. Chem. 270, 823-829
   Abstract »    Full Text »    PDF »
Quantitative Assessment of ALZ-50 Immunoreactivity in Alzheimer's Disease.
B.T. Hyman, J.E. Flory, S.E. Arnold, G.W. Van Hoesen, R.L. Schelper, H. Ghanbari, and H. Haigler (1991)
J Geriatr Psychiatry Neurol 4, 231-235
   Abstract »    PDF »
Expression of 'Alzheimer Antigens' in Cultured Skin Fibroblasts.
J. P. Blass, A. C. Baker, L.-w. Ko, R. K.-E. Sheu, and R. S. Black (1991)
Arch Neurol 48, 709-717
   Abstract »    PDF »
Increased ALZ-50-Reactive Neurons in the Brains of SIDS Infants: An Indicator of Greater Neuronal Death?.
D. L. Sparks and J. C. Hunsaker (1991)
J Child Neurol 6, 123-127
   Abstract »    PDF »
A68: a major subunit of paired helical filaments and derivatized forms of normal Tau.
V. Lee, B. Balin, L Otvos Jr, and J. Trojanowski (1991)
Science 251, 675-678
   Abstract »    PDF »
Biochemical Assay of Alzheimer's Disease--Associated Protein(s) in Human Brain Tissue: A Clinical Study.
H. A. Ghanbari, B. E. Miller, H. J. Haigler, M. Arato, G. Bissette, P. Davies, C. B. Nemeroff, E. K. Perry, R. Perry, R. Ravid, et al. (1990)
JAMA 263, 2907-2910
   Abstract »    PDF »
Diagnosing Alzheimer's Disease Clinically: How Well Do We Do?.
(1990)
J Geriatr Psychiatry Neurol 3, 53-54
   PDF »
Alzheimer's Disease--What the Practicing Clinician Needs to Know.
M. A. Jenike (1988)
J Geriatr Psychiatry Neurol 1, 37-46
   PDF »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)